10-K Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 FY 2024

Filing Information

Form Type	10-K
Accession Number	`0001628280-24-049277`
Period End Date	20240930
Filing Date	20241126
Fiscal Year	2024
Fiscal Period	FY
XBRL Instance	arwr-20240930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 146 Income Statement 126 Cash Flow Statement 202 Stockholders Equity 58

Balance Sheet 146 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.43M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.43M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	124.38M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	124.38M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.31M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.31M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$292.74M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$292.74M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$578.28M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$578.28M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	124.38M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	124.38M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.31M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.31M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.54M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.54M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$8.81M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$8.81M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.97M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.97M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.03M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.03M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$416.47M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$416.47M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$695.47M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$695.47M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$386.03M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$386.03M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$290.26M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$290.26M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$10.26M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$10.26M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.56M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.56M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.26M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.26M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.30M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.30M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.48M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.48M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.26M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.26M	USD	Point-in-time
Total Assets	`Assets`	$1.14B	USD	Point-in-time
Total Assets	`Assets`	$1.14B	USD	Point-in-time
Total Assets	`Assets`	$765.55M	USD	Point-in-time
Total Assets	`Assets`	$765.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$35.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$35.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.39M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.39M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$63.02M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$63.02M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$39.76M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$39.76M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$17.96M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$17.96M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$21.99M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$21.99M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.34M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.34M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$10.56M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$10.56M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$866.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$866.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$435.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$435.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$432.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$432.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$103.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$103.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.46M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$111.03M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$111.03M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$104.61M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$104.61M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	-	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	-	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$341.36M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$341.36M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$268.33M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$268.33M	USD	Point-in-time
Credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Credit facility	`LongTermLineOfCredit`	$393.18M	USD	Point-in-time
Credit facility	`LongTermLineOfCredit`	$393.18M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$372.93M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$372.93M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$845.57M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$845.57M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,376 and 107,312 shares	`CommonStockValue`	$200.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,376 and 107,312 shares	`CommonStockValue`	$200.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,376 and 107,312 shares	`CommonStockValue`	$217.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,376 and 107,312 shares	`CommonStockValue`	$217.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.30B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.30B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.81B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.81B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.22M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.22M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.75M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.03B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.03B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.63B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.63B	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$271.34M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$271.34M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$185.44M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$185.44M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$5.62M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$5.62M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.82M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.82M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Total noncontrolling interest and stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$1.14B	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$1.14B	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$765.55M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$765.55M	USD	Point-in-time

Income Statement 126 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$243.23M	USD	Annual
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$243.23M	USD	Annual
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$240.74M	USD	Annual
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$240.74M	USD	Annual
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.55M	USD	Annual
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.55M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$353.19M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$353.19M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$505.87M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$505.87M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$297.31M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$297.31M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$98.76M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$98.76M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$124.43M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$124.43M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$92.55M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$92.55M	USD	Annual
Total operating expenses	`OperatingExpenses`	$421.74M	USD	Annual
Total operating expenses	`OperatingExpenses`	$421.74M	USD	Annual
Total operating expenses	`OperatingExpenses`	$445.74M	USD	Annual
Total operating expenses	`OperatingExpenses`	$445.74M	USD	Annual
Total operating expenses	`OperatingExpenses`	$604.63M	USD	Annual
Total operating expenses	`OperatingExpenses`	$604.63M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-178.51M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-178.51M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-205.00M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-205.00M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-601.08M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-601.08M	USD	Annual
Interest income	`InvestmentIncomeInterestAndDividend`	$22.72M	USD	Annual
Interest income	`InvestmentIncomeInterestAndDividend`	$22.72M	USD	Annual
Interest income	`InvestmentIncomeInterestAndDividend`	$5.03M	USD	Annual
Interest income	`InvestmentIncomeInterestAndDividend`	$5.03M	USD	Annual
Interest income	`InvestmentIncomeInterestAndDividend`	$15.30M	USD	Annual
Interest income	`InvestmentIncomeInterestAndDividend`	$15.30M	USD	Annual
Interest expense	`InterestExpenseNonoperating`	-	USD	Annual
Interest expense	`InterestExpenseNonoperating`	-	USD	Annual
Interest expense	`InterestExpenseNonoperating`	$32.35M	USD	Annual
Interest expense	`InterestExpenseNonoperating`	$32.35M	USD	Annual
Interest expense	`InterestExpenseNonoperating`	$18.33M	USD	Annual
Interest expense	`InterestExpenseNonoperating`	$18.33M	USD	Annual
Other, net	`OtherNonoperatingIncomeExpense`	$1.54M	USD	Annual
Other, net	`OtherNonoperatingIncomeExpense`	$1.54M	USD	Annual
Other, net	`OtherNonoperatingIncomeExpense`	$-1.75M	USD	Annual
Other, net	`OtherNonoperatingIncomeExpense`	$-1.75M	USD	Annual
Other, net	`OtherNonoperatingIncomeExpense`	$765.00K	USD	Annual
Other, net	`OtherNonoperatingIncomeExpense`	$765.00K	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$-1.49M	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$-1.49M	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$5.80M	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$5.80M	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$-11.38M	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$-11.38M	USD	Annual
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-612.46M	USD	Annual
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-612.46M	USD	Annual
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-206.49M	USD	Annual
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-206.49M	USD	Annual
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-172.71M	USD	Annual
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-172.71M	USD	Annual
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$2.78M	USD	Annual
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$2.78M	USD	Annual
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$3.79M	USD	Annual
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$3.79M	USD	Annual
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-2.77M	USD	Annual
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-2.77M	USD	Annual
Net loss including noncontrolling interest	`ProfitLoss`	$-209.28M	USD	Annual
Net loss including noncontrolling interest	`ProfitLoss`	$-209.28M	USD	Annual
Net loss including noncontrolling interest	`ProfitLoss`	$-176.49M	USD	Annual
Net loss including noncontrolling interest	`ProfitLoss`	$-176.49M	USD	Annual
Net loss including noncontrolling interest	`ProfitLoss`	$-609.69M	USD	Annual
Net loss including noncontrolling interest	`ProfitLoss`	$-609.69M	USD	Annual
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-10.20M	USD	Annual
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-10.20M	USD	Annual
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.00M	USD	Annual
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.00M	USD	Annual
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-431.00K	USD	Annual
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-431.00K	USD	Annual
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-205.28M	USD	Annual
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-205.28M	USD	Annual
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-599.49M	USD	Annual
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-599.49M	USD	Annual
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-176.06M	USD	Annual
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-176.06M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-5.00	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-5.00	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.92	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.92	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.67	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.67	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-5.00	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-5.00	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.92	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.92	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.67	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.67	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.43M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.43M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	119.78M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	119.78M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.75M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.75M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	106.75M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	106.75M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.78M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.78M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.43M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.43M	shares	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.96M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.96M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.77M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.77M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.20M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.20M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-67.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-67.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-176.56M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-176.56M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-601.72M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-601.72M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-212.36M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-212.36M	USD	Annual

Cash Flow Statement 202 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-209.28M	USD	Annual
Net loss	`ProfitLoss`	$-209.28M	USD	Annual
Net loss	`ProfitLoss`	$-176.49M	USD	Annual
Net loss	`ProfitLoss`	$-176.49M	USD	Annual
Net loss	`ProfitLoss`	$-609.69M	USD	Annual
Net loss	`ProfitLoss`	$-609.69M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$73.97M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$73.97M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$78.13M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$78.13M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$120.89M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$120.89M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$12.49M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$12.49M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$10.42M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$10.42M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$18.59M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$18.59M	USD	Annual
(Accretion) Amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-2.91M	USD	Annual
(Accretion) Amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-2.91M	USD	Annual
(Accretion) Amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$2.02M	USD	Annual
(Accretion) Amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$2.02M	USD	Annual
(Accretion) Amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$3.24M	USD	Annual
(Accretion) Amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$3.24M	USD	Annual
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	-	USD	Annual
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	-	USD	Annual
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$23.04M	USD	Annual
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$23.04M	USD	Annual
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$18.33M	USD	Annual
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$18.33M	USD	Annual
Non-cash interest expense on credit facility	`PaidInKindInterest`	-	USD	Annual
Non-cash interest expense on credit facility	`PaidInKindInterest`	-	USD	Annual
Non-cash interest expense on credit facility	`PaidInKindInterest`	-	USD	Annual
Non-cash interest expense on credit facility	`PaidInKindInterest`	-	USD	Annual
Non-cash interest expense on credit facility	`PaidInKindInterest`	$9.32M	USD	Annual
Non-cash interest expense on credit facility	`PaidInKindInterest`	$9.32M	USD	Annual
Realized loss on investments	`RealizedInvestmentGainsLosses`	$-80.00K	USD	Annual
Realized loss on investments	`RealizedInvestmentGainsLosses`	$-80.00K	USD	Annual
Realized loss on investments	`RealizedInvestmentGainsLosses`	$-4.43M	USD	Annual
Realized loss on investments	`RealizedInvestmentGainsLosses`	$-4.43M	USD	Annual
Realized loss on investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Realized loss on investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.41M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.41M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-8.85M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-8.85M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$19.29M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$19.29M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.66M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.66M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-11.60M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-11.60M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-6.59M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-6.59M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$33.00M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$33.00M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.54M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.54M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$32.12M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$32.12M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$17.75M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$17.75M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-14.96M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-14.96M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-112.50M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-112.50M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-866.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-866.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-129.18M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-129.18M	USD	Annual
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$13.43M	USD	Annual
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$13.43M	USD	Annual
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$46.59M	USD	Annual
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$46.59M	USD	Annual
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$2.24M	USD	Annual
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$2.24M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	-	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	-	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.20M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.20M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$65.00K	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$65.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-462.85M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-462.85M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-136.13M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-136.13M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-153.89M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-153.89M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$52.78M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$52.78M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$141.47M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$141.47M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$176.74M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$176.74M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$246.14M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$246.14M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$223.39M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$223.39M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$720.95M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$720.95M	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$270.75M	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$270.75M	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$442.34M	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$442.34M	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$326.72M	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$326.72M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-420.07M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-420.07M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-96.16M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-96.16M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.42M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.42M	USD	Annual
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$429.26M	USD	Annual
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$429.26M	USD	Annual
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	-	USD	Annual
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	-	USD	Annual
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$50.00M	USD	Annual
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$50.00M	USD	Annual
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$250.00M	USD	Annual
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$250.00M	USD	Annual
Proceeds from credit facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Proceeds from credit facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Proceeds from credit facility	`ProceedsFromLongTermLinesOfCredit`	$392.00M	USD	Annual
Proceeds from credit facility	`ProceedsFromLongTermLinesOfCredit`	$392.00M	USD	Annual
Proceeds from credit facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Proceeds from credit facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$3.13M	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$3.13M	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$2.39M	USD	Annual
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$2.39M	USD	Annual
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$5.19M	USD	Annual
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$5.19M	USD	Annual
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$3.05M	USD	Annual
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$3.05M	USD	Annual
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	-	USD	Annual
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	-	USD	Annual
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	-	USD	Annual
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	-	USD	Annual
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	$60.00M	USD	Annual
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	$60.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$65.19M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$65.19M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$870.52M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$870.52M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$253.05M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$253.05M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-12.40M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-12.40M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.01M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.01M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-76.36M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-76.36M	USD	Annual
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-122.00K	USD	Annual
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-122.00K	USD	Annual
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.20M	USD	Annual
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.20M	USD	Annual
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-67.00K	USD	Annual
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-67.00K	USD	Annual
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.43M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.43M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.43M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.43M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.69M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
Income Taxes Paid	`IncomeTaxesPaidNet`	$-2.00K	USD	Annual
Income Taxes Paid	`IncomeTaxesPaidNet`	$-2.00K	USD	Annual
Income Taxes Paid	`IncomeTaxesPaidNet`	-	USD	Annual
Income Taxes Paid	`IncomeTaxesPaidNet`	-	USD	Annual
Income Taxes Paid	`IncomeTaxesPaidNet`	$-3.74M	USD	Annual
Income Taxes Paid	`IncomeTaxesPaidNet`	$-3.74M	USD	Annual
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$14.04M	USD	Annual
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$14.04M	USD	Annual
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$4.21M	USD	Annual
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$4.21M	USD	Annual
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$17.58M	USD	Annual
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$17.58M	USD	Annual
Debt issuance costs included in accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	-	USD	Annual
Debt issuance costs included in accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	-	USD	Annual
Debt issuance costs included in accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	-	USD	Annual
Debt issuance costs included in accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	-	USD	Annual
Debt issuance costs included in accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	$5.00M	USD	Annual
Debt issuance costs included in accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	$5.00M	USD	Annual

Stockholders Equity 58 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$73.97M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$73.97M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$120.89M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$120.89M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$78.13M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$78.13M	USD	Annual
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	226,004.00	shares	Annual
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	226,004.00	shares	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.39M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.39M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.05M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.05M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.18M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.18M	USD	Annual
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Common stock issued, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$429.26M	USD	Annual
Common stock issued, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$429.26M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.96M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.96M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.77M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.77M	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	Annual
Unrealized gains (losses) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.20M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.20M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-67.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-67.00K	USD	Annual
Interest in joint venture	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$60.00M	USD	Annual
Interest in joint venture	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$60.00M	USD	Annual
Net loss	`ProfitLoss`	$-209.28M	USD	Annual
Net loss	`ProfitLoss`	$-209.28M	USD	Annual
Net loss	`ProfitLoss`	$-176.49M	USD	Annual
Net loss	`ProfitLoss`	$-176.49M	USD	Annual
Net loss	`ProfitLoss`	$-609.69M	USD	Annual
Net loss	`ProfitLoss`	$-609.69M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$191.06M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.